Clinical Study

Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Table 2

Classification of steatosis in NAFLD before and after treatment.

ā€‰MildModerateSevereTotal
ā€‰BeforeAfterBeforeAfterBeforeAfter

Group 113 (26.0%)27 (54.0%)22 (44.0%)16 (32.0%)15 (30.0%)7 (14.0%)50 (100%)
Group 216 (32.0%)26 (52.0%)21 (42.0%)14 (28.0%)13 (26.0%)10 (20.0%)50 (100%)
Group 314 (30.4%)37 (80.4%)22 (47.8%)7 (15.2%)10 (21.7%)2 (4.3%)50 (100%)